IRDAI commission-cap proposal pushes PB Fintech below its listing price
PB Fintech shares fell below their Rs 1,150 listing price after IRDAI proposed commission caps. Policybazaar expects the move to cut health-business NPV by 60–70%, prompting plans to reduce marketing spend, slow hiring and build manufacturing, broking and servicing income streams.
What happened
PB Fintech fell below its listing price after IRDAI proposed commission caps. Policybazaar expects health-business NPV to decline 60-70%, and plans to trim
Key facts
- Rs 1,115.10 share low
- Rs 1,150 listing price
- 11.64% fall from intraday high
- Rs 1,262 intraday high
- 60-70% expected reduction in health-business NPV
What changed
PB Fintech fell below its listing price after IRDAI proposed commission caps. Policybazaar expects health-business NPV to decline 60-70%, and plans to trim marketing, slow hiring and add insurance-manufacturing, broking and servicing revenue streams.
Why this matters
IRDAI’s proposed commission caps create a material earnings-reset risk for PB Fintech, with management estimating a 60–70% reduction in health-business NPV and signaling reduced growth investment.
What to watch
- Final IRDAI wording, cap levels, product coverage, exemptions and implementation date.
- Whether commission restrictions apply equally to online aggregators, brokers, corporate agents, banks and individual agents.
- Management's revised health-growth, EBITDA and adjusted-EBITDA guidance.
- Quarterly marketing spend, new-policy growth, CAC, conversion rates and renewal/renewal-commission trends.
- Insurer responses: changes to product pricing, distributor payouts, service-fee structures and direct-to-consumer promotion.